Zombie Company

What this company is

A Zombie Company (Zombie Company) is clinically alive: its operating profit doesn't even cover the interest on its debt for three years in a row. It lives by borrowing again to pay interest on earlier borrowing, so it neither repays principal nor grows, and it keeps walking as long as the debt market lends a hand.

Why they multiply and get exposed in cycles

They multiply in eras of cheap money: near-zero rates keep any body moving because everything is refinanced without questions. They get exposed when rates rise: every maturing debt is renewed at twice the cost. Waves of distress don't arrive right when rates rise but with the next maturity wall. The bomb is timed by the refinancing calendar, not the hiking decision.

Why it matters to the whole market reader

Their mass is a gauge of hidden economic fragility: an inflated share means part of the headline "growth" walks on the crutches of cheap debt, and that monetary tightening will harvest a whole sector at once: layoffs, bankruptcies and credit stress that cascades to their lenders.

Hypothetical example

A company with operating profit of 40 million and interest of 65 closes the gap by issuing new debt every year. A maturity wall arrives with doubled rates and interest becomes 110. Distress is no longer an option but an appointment. Its stock looked "cheap" on any naive multiple.

Common mistake

Hunting "cheap bottoms" among them: a low P/E with weak interest coverage isn't cheapness but the price of a postponed funeral. Check interest coverage and the debt maturity schedule before getting excited about a tempting multiple.

Where to see it on the platform

The sector comparison module shows interest coverage ratios from official data, so you see the crutch before buying what walks on it.